Loading…
Diarylether‐Amino Acid Conjugates as New Class of Anticancer Agents
Diarylether (DE) is a privileged structure found in both natural products and synthetic compounds including small molecule drugs. We present the synthesis of a series of 13 new DE‐amino acid conjugates which were screened for cancer cells antiproliferation activity. Structure‐activity relationship s...
Saved in:
Published in: | ChemistrySelect (Weinheim) 2023-07, Vol.8 (28), p.n/a |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Diarylether (DE) is a privileged structure found in both natural products and synthetic compounds including small molecule drugs. We present the synthesis of a series of 13 new DE‐amino acid conjugates which were screened for cancer cells antiproliferation activity. Structure‐activity relationship suggests ester and phenyl groups in DE‐Phe‐OEt 4 c are important for the activity. Compound 4 c inhibited strongly MCF‐7 3D tumor sphere formation and have favourable calculated physical chemical properties according to Lipinski's rule of 5. Docking study suggests estrogen receptor and/ or 3a‐HSD type 3 protein could be the target(s) for anticancer activity of this class of compounds.
Diarylether (DE) – amino acid conjugate such as the oral drug roxadustat represents attractive scaffold for discovery of new bioactive compounds. We designed and synthesized a series of new DE – natural amino acid conjugates which were screened for anticancer activity. Among these, the drug like phenylalanine derivative 4 c inhibited strongly MCF‐7 3D tumor sphere formation thus represents attractive scaffold for further optimization and mechanistic study. |
---|---|
ISSN: | 2365-6549 2365-6549 |
DOI: | 10.1002/slct.202301203 |